Atta Behfar, M.D., Ph.D., and Andre Terzic, M.D., Ph.D., lead the Mayo Clinic Van Cleve Regenerative Medicine Program. Team science

Research in the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program is led by Atta Behfar, M.D., Ph.D., and Andre Terzic, M.D., Ph.D., supported by a dedicated administrative staff, and carried out by expert researchers and M.D.-Ph.D. students.

Leading Team Science in Regenerative Medicine

Program leadership

  • Atta Behfar, M.D., Ph.D.
    • Director, Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program
    • Deputy Director of Translation, Center for Regenerative Medicine
    • Dr. Behfar is a transplant cardiologist and stem cell biologist with a focus on cardiovascular regeneration.
    • Publications
  • Andrew (Drew) N. Rosenbaum, M.D.
    • Senior Associate Consultant, Regenerative Clinical Translation
    • Dr. Rosenbaum is focused on the hemodynamics of mechanical circulatory support. He supports the clinical arm of the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program and is also involved in the program's preclinical projects.
    • Publications
  • Andre Terzic, M.D., Ph.D.

Administrative staff

  • Allison J. Pedretti
    • Ms. Pedretti supports scheduling and coordination within the program.
  • Paul G. Stalboerger, M.S., PMP
    • Mr. Stalboerger focuses on managing the program to ensure operational alignment with the strategic vision and overarching mission.

Research team

  • David (D Kent) K. Arrell, Ph.D.
    • Dr. Arrell has expertise in specialized tools to study and quantify proteins in heart tissue and stem cells.
    • Publications
  • Zeji Du, Ph.D.
    • Dr. Du is a molecular biology expert focused on developing nonviral gene delivery approaches and technologies for regenerative therapies.
    • Publications
  • Erin L. Gillmore
    • Ms. Gillmore is a clinical coordinator supporting Dr. Behfar's clinical activities for the program.
  • Matthew L. Hillestad, Ph.D.
    • Dr. Hillestad is a gene therapy expert focused on developing cardiac-targeted technologies to deliver novel regenerative therapies to the heart.
    • Publications
  • Ryan C. Mahlberg, M.S.
    • Mr. Mahlberg has an extensive background in histology and immunological staining. He supports preclinical studies and innovation within the program.
  • Dhivya V (Dhivya Vadhana) Meenakshi Siddharthan, Ph.D.
    • Dr. Meenakshi Siddharthan is identifying new therapeutic targets at the gene and protein levels using samples from patients.
  • Mary E. Nagel
    • Ms. Nagel supports surgical care and investigative models to enhance the mission and vision of the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program.
  • Sungjo Park, Ph.D.
    • Dr. Park is an expert in protein structure and mechanics. He is utilizing nanoimaging tools to inform the design of biologics-based regenerative therapies.
    • Publications
  • Timothy E. Peterson, M.S.
    • Mr. Peterson is a protein chemist who designs customized extracellular vesicles for regenerative medicine.
    • Publications
  • Michael S. Sabbah, M.D.
    • Dr. Sabbah is a National Institutes of Health clinician-investigator fellow in Mayo Clinic's Cardiovasology Training Program. He works to translate innovative regenerative therapies from the lab bench to the patient bedside.
    • Publications
  • Tyra A. Witt
    • Ms. Witt is developing avenues in surgical supportive care and investigative models to support the program's mission.
    • Publications

M.D.-Ph.D. students

  • Skylar A. Rizzo
    • Ms. Rizzo is an M.D.-Ph.D. student working on developing exosomes into a gene-delivery tool.
  • Amanda R. Terlap
    • Ms. Terlap is a doctoral student focused on developing gene and antiviral therapies for regenerative platforms.

Postdocs and clinical fellows

  • Mohsin Abbas, M.B.B.S.
    • Dr. Abbas is a clinical research fellow. He works in cardiac interventional and imaging laboratories, with a focus on using advanced innovative tools — including transcriptomics and artificial intelligence — to provide patients with the best possible, least invasive, and most accessible diagnostic and therapeutic care possible.
    • Publications
  • Kobra (Parisa) P. Kargaran, Ph.D.
    • Dr. Kargaran works on the optimization of cardiopoiesis for therapeutic and diagnostic applications in heart disease.
    • Publications